Home / Products / AloCell-ENDO

AloCell-ENDO

Medical fields of application:

Composition:

cultured allogeneic mesenchymal stem cells (MSCs) derived from umbilical cord.

Contact our call center consultant
(Mon-Fri, 9:00-18:00):

+38 (066) 660-31-16

Indications:

Recommended use:

50 million MSCs, intravenous infusion at 1 ml/min (2 procedures, 3 months apart; repeat administration of 50 million MSCs)
20 million MSCs, intramuscular injection into the affected lower limb (2 procedures, 4 weeks apart)
20 million MSCs, intracavernosal injection (2 procedures, 4 weeks apart)

Packaging:

pre-filled syringes or 2 ml, 5 ml, and 10 ml glass vials containing cell suspension.

Catalog of advanced therapy drugs of the Center for Modern Cellular Technologies ReoCell View
Methodological recommendations – Cultured autologous and allogeneic mesenchymal stem cells of bone marrow in the complex treatment of patients with chondral injuries and osteoarthritis of synovial joints View
Methodological recommendations – Treatment of patients with severe forms of lower limb ischemia of atherosclerotic genesis with autologous mesenchymal stem cells View
Methodological recommendations – Optimization of the dosage of mesenchymal stem cells when used in the therapy of various pathological conditions and organization of medical care View
Methodological recommendations – Use of allogeneic mesenchymal stem cells in type 2 diabetes complicated by diabetic angiopathy of the lower extremities with/without the presence of trophic ulcers View
Methodological recommendations – Use of allogeneic mesenchymal stem cells in senile asthenia View

Order in one click

Call me back